FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

76111000001105: Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16853501000001114 Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
68691601000001110 Tertroxin 20microgram tablets (Mercury Pharma Group Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Is a Product containing precisely liothyronine sodium 20 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Has active ingredient Liothyronine false Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Has active ingredient Liothyronine sodium false Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Is a Tertroxin true Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Has specific active ingredient Liothyronine sodium true Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) 100 tablet Is pack of False Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Inferred relationship Existential restriction modifier
Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) 100 tablet Has AMP True Tertroxin 20microgram tablets (Goldshield Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start